<p>Real time PCR results for A) GLUT1, B) GLUT2, C) SGLT1 and D) SGLT2 expressed relative to actin. Expression levels of renal GLUT1 protein (E and F) and SGLT2 (G and H) relative to actin (Data are expressed as mean ± SEM with # = P<0.05 vs dm).</p
Abstract Background Arterial stiffness is emerging as an independent risk factor for the development...
(1) Background: empagliflozin, sodium-glucose co-transporter 2 (SGLT-2) inhibitor, is an effective a...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors confer profound cardiorenal protection in type 2 d...
<p>Real time PCR results for Renal cortical transcription of A) MCP-1, B) Collagen 4, C) TGFβ and D)...
Blood glucose control is the primary strategy to prevent complications in diabetes. At the onset of ...
Blood glucose control is the primary strategy to prevent complications in diabetes. At the onset of ...
Sodium glucose cotransporter 2 (SGLT2) is the main luminal glucose transporter in the kidney. SGLT2 ...
<p><b>Panel</b> A shows RT-PCR analysis of SGLT1, Na<sup>+</sup>/k<sup>+</sup>-ATPase and GLUT2 mRNA...
<p><b>(A)</b> Diabetic mice demonstrated increased cortical fibronectin mRNA transcription by real t...
Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patient...
<p>Representative photographs of PAS stained sections for A) ctrl, B) ctrl + empa, C) dm, D) dm + em...
<p>Similar findings were observed for CTGF, Nephrin, TSP1 and Fn proteins (<b>B to F</b>). Total RNA...
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associa...
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associa...
IntroductionDiabetic kidney disease (DKD) has become the leading cause of end-stage renal disease wo...
Abstract Background Arterial stiffness is emerging as an independent risk factor for the development...
(1) Background: empagliflozin, sodium-glucose co-transporter 2 (SGLT-2) inhibitor, is an effective a...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors confer profound cardiorenal protection in type 2 d...
<p>Real time PCR results for Renal cortical transcription of A) MCP-1, B) Collagen 4, C) TGFβ and D)...
Blood glucose control is the primary strategy to prevent complications in diabetes. At the onset of ...
Blood glucose control is the primary strategy to prevent complications in diabetes. At the onset of ...
Sodium glucose cotransporter 2 (SGLT2) is the main luminal glucose transporter in the kidney. SGLT2 ...
<p><b>Panel</b> A shows RT-PCR analysis of SGLT1, Na<sup>+</sup>/k<sup>+</sup>-ATPase and GLUT2 mRNA...
<p><b>(A)</b> Diabetic mice demonstrated increased cortical fibronectin mRNA transcription by real t...
Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patient...
<p>Representative photographs of PAS stained sections for A) ctrl, B) ctrl + empa, C) dm, D) dm + em...
<p>Similar findings were observed for CTGF, Nephrin, TSP1 and Fn proteins (<b>B to F</b>). Total RNA...
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associa...
Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associa...
IntroductionDiabetic kidney disease (DKD) has become the leading cause of end-stage renal disease wo...
Abstract Background Arterial stiffness is emerging as an independent risk factor for the development...
(1) Background: empagliflozin, sodium-glucose co-transporter 2 (SGLT-2) inhibitor, is an effective a...
Sodium-glucose cotransporter 2 (SGLT2) inhibitors confer profound cardiorenal protection in type 2 d...